Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Apr;21(4):377–383. doi: 10.1111/j.1365-2125.1986.tb05210.x

Slow release nifedipine and atenolol as initial treatment in blacks with malignant hypertension.

C G Isles, A O Johnson, F J Milne
PMCID: PMC1400940  PMID: 3518771

Abstract

We have compared the efficacy and safety of slow release nifedipine and atenolol given orally as initial treatment for malignant hypertension. Twenty consecutive black patients with untreated malignant hypertension, whose diastolic pressure remained greater than 120 mm Hg after 3 h bed rest, were randomized to receive either slow release nifedipine 40 mg at 1 and 12 h, or atenolol 100 mg at 0 h only. Patients remained supine throughout the study. Blood pressure was measured using a semi-automatic recorder (Omega 1000) at 15 min intervals from -3 to 24 h. Baseline blood pressure was similar in the nifedipine (233/142 mm Hg) and atenolol (226/141 mm Hg) groups. The rate of fall of pressure was greater after nifedipine whose maximum hypotensive effect occurred 4-5 h after each dose. Blood pressure decreased more slowly and more enduringly after atenolol, although the extent of fall was the same (delta BP 5 h after first dose nifedipine = 67/41 mm Hg; delta BP 16 h after atenolol = 64/40 mm Hg). There were no precipitous falls in pressure. No patient developed focal neurological signs, nor was heart failure precipitated by either form of treatment. These results support recommendations that most patients with malignant hypertension can be managed without recourse to parenteral therapy.

Full text

PDF
377

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen G. S., Ahn H. S., Preziosi T. J., Battye R., Boone S. C., Boone S. C., Chou S. N., Kelly D. L., Weir B. K., Crabbe R. A. Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983 Mar 17;308(11):619–624. doi: 10.1056/NEJM198303173081103. [DOI] [PubMed] [Google Scholar]
  2. Bannan L. T., Beevers D. G. Emergency treatment of high blood pressure with oral atenolol. Br Med J (Clin Res Ed) 1981 May 30;282(6278):1757–1758. doi: 10.1136/bmj.282.6278.1757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bertel O., Conen D., Radü E. W., Müller J., Lang C., Dubach U. C. Nifedipine in hypertensive emergencies. Br Med J (Clin Res Ed) 1983 Jan 1;286(6358):19–21. doi: 10.1136/bmj.286.6358.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown J. J., Davies D. L., Lever A. F., Robertson J. I. Plasma Renin Concentration in Human Hypertension-III: Renin in Relation to Complications of Hypertension. Br Med J. 1966 Feb 26;1(5486):505–508. doi: 10.1136/bmj.1.5486.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cohen S. L., Jhetam D., Da Silva J., Milne F. J., van der Walt A. Sodium and potassium status, plasma renin and aldosterone profiles in normotensive and hypertensive Johannesburg blacks. S Afr Med J. 1982 Dec 11;62(25):941–944. [PubMed] [Google Scholar]
  6. Cove D. H., Seddon M., Fletcher R. F., Dukes D. C. Blindness after treatment for malignant hypertension. Br Med J. 1979 Jul 28;2(6184):245–246. doi: 10.1136/bmj.2.6184.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Erbel R., Brand G., Meyer J., Effert S. Emergency treatment of hypertensive crisis with sublingual nifedipine. Postgrad Med J. 1983;59 (Suppl 3):134–136. [PubMed] [Google Scholar]
  8. Gold C. H., Isaacson C., Levin J. The pathological basis of end-stage renal disease in blacks. S Afr Med J. 1982 Feb 20;61(8):263–265. [PubMed] [Google Scholar]
  9. Graham D. I. Ischaemic brain damage of cerebral perfusion failure type after treatment of severe hypertension. Br Med J. 1975 Dec 27;4(5999):739–739. doi: 10.1136/bmj.4.5999.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Humphreys G. S., Delvin D. G. Ineffectiveness of propranolol in hypertensive Jamaicans. Br Med J. 1968 Jun 8;2(5605):601–603. doi: 10.1136/bmj.2.5605.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Isaacson C. Pathological changes in hypertension. S Afr Med J. 1978 Jun 14;53(24):994–996. [PubMed] [Google Scholar]
  12. Jhetam D., Dansey R., Morar C., Milne F. J. The malignant phase of essential hypertension in Johannesburg Blacks. A prospective study. S Afr Med J. 1982 Jun 12;61(24):899–902. [PubMed] [Google Scholar]
  13. Lawton W. J. The short-term course of renal function in malignant hypertensives with renal insufficiency. Clin Nephrol. 1982 Jun;17(6):277–283. [PubMed] [Google Scholar]
  14. Ledingham J. G., Rajagopalan B. Cerebral complications in the treatment of accelerated hypertension. Q J Med. 1979 Jan;48(189):25–41. [PubMed] [Google Scholar]
  15. McLeod D., Marshall J., Kohner E. M. Role of axoplasmic transport in the pathophysiology of ischaemic disc swelling. Br J Ophthalmol. 1980 Apr;64(4):247–261. doi: 10.1136/bjo.64.4.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pitlik S., Manor R. S., Lipshitz I., Perry G., Rosenfeld J. Transient retinal ischaemia induced by nifedipine. Br Med J (Clin Res Ed) 1983 Dec 17;287(6408):1845–1846. doi: 10.1136/bmj.287.6408.1845-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. REEF H., ISAACSON C. Atherosclejosis in the Bantu. The distribution of atheromatous lesions in Africans over 50 years of age. Circulation. 1962 Jan;25:66–72. doi: 10.1161/01.cir.25.1.66. [DOI] [PubMed] [Google Scholar]
  18. Seedat Y. K. Trial of atenolol and chlorthalidone for hypertension in black South Africans. Br Med J. 1980 Nov 8;281(6250):1241–1243. doi: 10.1136/bmj.281.6250.1241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation. 1976 Apr;53(4):720–727. doi: 10.1161/01.cir.53.4.720. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES